product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
A20/TNFAIP3 Antibody (59A426) - BSA Free
catalog :
NBP1-77533
quantity :
0.1 mg (also 0.025 mg)
price :
489 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
59A426
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section
more info or order :
citations: 42
Published Application/Species/Sample/DilutionReference
  • western blot; human
Reihill J, Malcomson B, Bertelsen A, Cheung S, Czerwiec A, Barsden R, et al. Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells. Br J Pharmacol. 2016;173:778-89 pubmed publisher
  • western blot; mouse
Perez C, Jukica A, Listopad J, Anders K, Kühl A, Loddenkemper C, et al. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts. Int J Cancer. 2015;137:359-71 pubmed publisher
  • western blot; mouse
De A, Dainichi T, RATHINAM C, Ghosh S. The deubiquitinase activity of A20 is dispensable for NF-?B signaling. EMBO Rep. 2014;15:775-83 pubmed publisher
Wang Y, Liu T, Shen C, Lin S, Hung C, Hsu L, et al. K48/K63-linked polyubiquitination of ATG9A by TRAF6 E3 ligase regulates oxidative stress-induced autophagy. Cell Rep. 2022;38:110354 pubmed publisher
Tran V, Ju H. Fluorescence Based on Surface Plasmon Coupled Emission for Ultrahigh Sensitivity Immunoassay of Cardiac Troponin I. Biomedicines. 2021;9: pubmed publisher
Feoktistova M, Makarov R, Brenji S, Schneider A, Hooiveld G, Luedde T, et al. A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes. Cells. 2020;9: pubmed publisher
Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, et al. Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma. Sci Rep. 2019;9:9162 pubmed publisher
Lim M, Maubach G, Sokolova O, Feige M, Diezko R, Buchbinder J, et al. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death. Cell Death Differ. 2017;24:1621-1631 pubmed publisher
Lai T, Wu S, Tsai M, Chuang E, Chuang L, Hsu L, et al. Transcription of Tnfaip3 is regulated by NF-?B and p38 via C/EBP? in activated macrophages. PLoS ONE. 2013;8:e73153 pubmed publisher
Svingerud T, Solstad T, Sun B, Nyrud M, Kileng y, Greiner Tollersrud L, et al. Atlantic salmon type I IFN subtypes show differences in antiviral activity and cell-dependent expression: evidence for high IFNb/IFNc-producing cells in fish lymphoid tissues. J Immunol. 2012;189:5912-23 pubmed publisher
Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood. 2011;118:3195-204 pubmed publisher
Gerlach B, Cordier S, Schmukle A, Emmerich C, Rieser E, Haas T, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471:591-6 pubmed publisher
Hövelmeyer N, Reissig S, Xuan N, Adams Quack P, Lukas D, Nikolaev A, et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol. 2011;41:595-601 pubmed publisher
Adrianto I, Wen F, Templeton A, Wiley G, King J, Lessard C, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet. 2011;43:253-8 pubmed publisher
Imbeault M, Ouellet M, Giguère K, Bertin J, Bélanger D, Martin G, et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J Virol. 2011;85:2189-200 pubmed publisher
Malinverni C, Unterreiner A, Staal J, Demeyer A, Galaup M, Luyten M, et al. Cleavage by MALT1 induces cytosolic release of A20. Biochem Biophys Res Commun. 2010;400:543-7 pubmed publisher
Frenzel L, Claus R, Plume N, Schwamb J, Konermann C, Pallasch C, et al. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. Int J Cancer. 2011;128:2495-500 pubmed publisher
Harada Y, Kanehira M, Fujisawa Y, Takata R, Shuin T, Miki T, et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010;70:5829-39 pubmed publisher
Hjelmeland A, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol. 2010;8:e1000319 pubmed publisher
Hailfinger S, Lenz G, Ngo V, Posvitz Fejfar A, Rebeaud F, Guzzardi M, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2009;106:19946-51 pubmed publisher
Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, et al. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. Cancer. 2009;115:4783-94 pubmed publisher
Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood. 2009;114:2467-75 pubmed publisher
Duwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U, et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol. 2009;182:7718-28 pubmed publisher
Schmitz R, Hansmann M, Bohle V, Martin Subero J, Hartmann S, Mechtersheimer G, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206:981-9 pubmed publisher
Verhelst K, Verstrepen L, Coornaert B, Carpentier I, Beyaert R. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation. Methods Mol Biol. 2009;517:205-15 pubmed publisher
Breckpot K, Aerts Toegaert C, Heirman C, Peeters U, Beyaert R, Aerts J, et al. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine. J Immunol. 2009;182:860-70 pubmed
Li L, Soetandyo N, Wang Q, Ye Y. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim Biophys Acta. 2009;1793:346-53 pubmed publisher
Werner S, Kearns J, Zadorozhnaya V, Lynch C, O Dea E, Boldin M, et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev. 2008;22:2093-101 pubmed publisher
Li L, Hailey D, Soetandyo N, Li W, Lippincott Schwartz J, Shu H, et al. Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim Biophys Acta. 2008;1783:1140-9 pubmed publisher
Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J, et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol. 2008;9:263-71 pubmed publisher
Chevillard G, Derjuga A, Devost D, Zingg H, Blank V. Identification of interleukin-1beta regulated genes in uterine smooth muscle cells. Reproduction. 2007;134:811-22 pubmed
Bohgaki M, Tsukiyama T, Nakajima A, Maruyama S, Watanabe M, Koike T, et al. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim Biophys Acta. 2008;1783:826-37 pubmed
Zhang B, Guan C, Chen W, Zhang P, Yan M, Shi J, et al. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation. Chin Med J (Engl). 2007;120:1830-5 pubmed
Yokota S, Okabayashi T, Yokosawa N, Fujii N. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J. 2008;22:74-83 pubmed
Hutti J, Turk B, Asara J, Ma A, Cantley L, Abbott D. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol Cell Biol. 2007;27:7451-61 pubmed
Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?. Clin Cancer Res. 2007;13:4565-74 pubmed
Wang Y, Li L, Han K, Zhai Z, Shu H. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 2004;576:86-90 pubmed
Ke B, Shen X, Lassman C, Gao F, Busuttil R, Kupiec Weglinski J. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am J Transplant. 2003;3:1076-82 pubmed
Yang K, Arcaroli J, Kupfner J, Pitts T, Park J, Strasshiem D, et al. Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis. Cell Signal. 2003;15:225-33 pubmed
Ke B, Shen X, Zhai Y, Gao F, Busuttil R, Volk H, et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther. 2002;13:1845-57 pubmed
Wu W, Xu Z, Chang K. The promyelocytic leukemia protein represses A20-mediated transcription. J Biol Chem. 2002;277:31734-9 pubmed
Kupfner J, Arcaroli J, Yum H, Nadler S, Yang K, Abraham E. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J Immunol. 2001;167:7044-51 pubmed
product information
master code :
NBP1-77533
SKU :
NBP1-77533
product name :
A20/TNFAIP3 Antibody (59A426) - BSA Free
unit size :
0.1 mg (also 0.025 mg)
description :
The A20/TNFAIP3 Antibody (59A426) - BSA Free from Novus is a mouse monoclonal antibody to A20/TNFAIP3. This antibody reacts with human,mouse,rat. The A20/TNFAIP3 Antibody (59A426) - BSA Free has been validated for the following applications: Western Blot,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Immunohistochemistry,Immunoprecipitation,Immunohistochemistry-Paraffin,Flow (Intracellular),Simple Western,CyTOF-ready.
target :
A20/TNFAIP3
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
59A426
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Full length recombinant human A20/TNFAIP3 Antibody (59A426). The epitope has been mapped to the C-terminal portion of A20 (amino acids 440-790)
isotype :
IgG1 Kappa
purity :
Protein G purified
species :
Human,Mouse,Rat
gene symbol :
TNFAIP3
accessionNumbers :
P21580
applications :
Western Blot,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Immunohistochemistry,Immunoprecipitation,Immunohistochemistry-Paraffin,Flow (Intracellular),Simple Western,CyTOF-ready
USD :
489 USD
alt names :
A20TNFA1P2, EC 3.4.19.12, EC 6.3.2.-, MGC104522, MGC138687, OTU domain-containing protein 7C, OTUD7CMGC138688, Putative DNA-binding protein A20, TNF alpha-induced protein 3, tumor necrosis factor alpha-induced protein 3, tumor necrosis factor inducible protein A20, tumor necrosis factor, alpha-induced protein 3, Zinc finger protein A20
storage :
Store at -20C. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.